AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

Sales and UpgradesContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

10 May
AHFS Drug Information logo
AHFS May 2022 Update

This update contains 2 new monographs and 25 revised monographs.

New monographs: Nivolumab and Relatlimab-rmbw; Pacritinib

Revised monographs: Acalabrutinib; Adalimumab; Brigatinib; Brodalumab; Certolizumab; COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Eptinezumab-jjmr; Erenumab-aooe; Fremanezumab-vfrm; Glatiramer; Imatinib; Infigratinib; Lanadelumab; Lurbinectedin; Nilotinib; Nitroglycerin; PAZOPanib; Pramipexole; Rimegepant; Sotrovimab; Teduglutide; Tivozanib; Trihexyphenidyl; Upadacitinib

08 Apr
AHFS Drug Information logo
AHFS April 2022 Update

This update contains 3 new monographs and 61 revised monographs.

New monographs: Abrocitinib; Bebtelovimab; Faricimab

Revised monographs: Alprostadil; Alteplase; Amantadine; Amiodarone; Apremilast; Argatroban; Asparaginase (Erwinia chrysanthemi) (recombinant)-rywn; Avatrombopag; Belzutifan; Benztropine; Bumetanide; Cisatracurium; Dasatinib; Dexmedetomidine; dilTIAZem; Diroximel Fumarate; DOBUTamine; Dopamine; Dostarlimab-gxly; Eltrombopag; Epinephrine; Esmolol; Etanercept; fentaNYL; Furosemide; Heparin; HYDROmorphone; Ibrutinib; Insulin Human; Isoproterenol; Ketamine; Labetalol; LORazepam; Midazolam; Milrinone; Morphine; Naloxone; niCARdipine; Norepinephrine; Octreotide; Osimertinib; Pantoprazole; PENTobarbital; Phenylephrine; Pralsetinib; Propofol; Remifentanil; Ripretinib; Rocuronium; Sodium Bicarbonate; Sodium Chloride; Sodium Nitroprusside; Sonidegib; Temozolomide; Tepotinib; Terbutaline; Tranexamic Acid; Umbralisib; Vasopressin; Vecuronium; Venetoclax

08 Mar
AHFS Drug Information logo
AHFS March 2022 Update

This update contains 4 new monographs, 48 revised monographs, 12 discontinued monographs and 2 new MedWatch alerts.

New monographs: Inclisiran; Levoketoconazole; Ropeginterferon Alfa-2b; Tralokinumab

Revised monographs: Aflibercept; Aminopenicillins General Statement; Amoxicillin; Amoxicillin/Clavulanate; Ampicillin; Ampicillin/Sulbactam; Antihistamines General Statement; Argatroban; Avacopan; Bamlanivimab and Etesevimab; Berotralstat; Bevacizumab; Brolucizumab; Buprenorphine; C1-Esterase Inhibitor (Human); C1-Esterase Inhibitor (Recombinant); Casirivimab and Imdevimab; Clarithromycin; COVID-19 Vaccine (Janssen); COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Diroximel Fumarate; Ecallantide; Eculizumab; Icatibant; Ixazomib Citrate; Lanadelumab-flyo; Ledipasvir and Sofosbuvir; Lemborexant; Lenalidomide; Monomethyl Fumarate; Pegcetacoplan; Pomalidomide; Preface to Penicillins; Ranibizumab; Ravulizumab-cwvz; Remdesivir; Risankizumab-rzaa; Sofosbuvir; Sofosbuvir, Velpatasvir, and Voxilaprevir; Sotorasib; Suvorexant; Thalidomide; Thiazides General Statement; Tildrakizumab-asmn; Umbralisib; Varicella Virus Vaccine Live

Discontinued monographs: Ammonium Chloride; Bendroflumethiazide; Biperiden; chlorpropamide; Diphenido; Edrophonium; Indinavir; Lesinurad; Pegaptanib; Procyclidine; raNITIdine; Tromethamine

New MedWatch alerts on the following monographs: Buprenorphine; Umbralisib

08 Feb
AHFS Drug Information logo
AHFS February 2022 Update

This update contains 7 new monographs and 43 revised monographs.

New monographs: Efgartigimod Alfa-Fcab; Maribavir; Molnupiravir; Nirmatrelvir And Ritonavir; Tezepelumab; Tixagevimab And Cilgavimab; Vosoritide.

Revised monographs: Atorvastatin; Bamlanivimab and Etesevimab; Bivalirudin; Cangrelor; Casirivimab and Imdevimab; Clopidogrel; Cobimetinib; COVID-19 Vaccine (Janssen); COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Dexmethylphenidate/Serdexmethylphenidate; Diclofenac; Dimethyl Fumarate; Diroximel Fumarate; Entrectinib; Factor Xa (recombinant), Inactivated-zhzo; Fedratinib; Fluvastatin; Glasdegib; HMG-CoA Reductase Inhibitors General Statement; Hyperosmotic Laxatives; idaruCIZUmab; Iloperidone; Imipenem and Cilastatin; Ivosidenib; Lenvatinib; Loncastuximab; Lovastatin; Meningococcal Groups A, C, Y, and W-135 Vaccine; Methylphenidate; Monomethyl Fumarate; Palbociclib; Pitavastatin; Pravastatin; Prothrombin Complex Concentrate; Remdesivir; Rosuvastatin; Selpercatinib; Simvastatin; Sotrovimab; Sucroferric Oxyhydroxide; Sugammadex; Ursodiol

11 Jan
AHFS Drug Information logo
AHFS Drug Information January 2022 Update

This update contains 2 new monographs and 43 revised monographs.

New monographs: Asciminib; Tick-borne Encephalitis Vaccine

Revised monographs: Linezolid; Fondaparinux; Flurbiprofen; Bedaquiline; Olaparib; Obeticholic Acid; Rucaparib; Niraparib; Pretomanid; Lefamulin; Tazemetostat; Cefiderocol; Capmatinib; Ofatumumab; COVID-19 Vaccine (Pfizer-BioNTech); Relugolix; Fenoprofen; Indomethacin; Mefenamic Acid; Tolmetin; Sulindac; Prochlorperazine; Trifluoperazine; Perphenazine; fluPHENAZine; Neostigmine; Molindone; Meclofenamate; Loxapine; Chloroquine; Hydroxychloroquine; Thiothixene; Aspirin; Salsalate; Phenothiazines General Statement; Diflunisal; Piroxicam; Ketoprofen; Pimozide; cloZAPine; Etodolac; Nabumetone; Oxaprozin

07 Dec
AHFS Drug Information logo
AHFS December 2021 Update

This update contains 5 new monographs and 18 revised monographs.

New monographs: Clascoterone; Tisotumab Vedotin-tftv; Maralixibat; Atogepant; Avacopan

Revised monographs: Meloxicam; Influenza Vaccine Live Intranasal; Tocilizumab; Influenza Vaccine Recombinant; Atezolizumab; Brexpiprazole; Cariprazine; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Janssen); Naproxen; HYDROmorphone; Ibuprofen; Levodopa/Carbidopa; Diclofenac; Ketorolac; Influenza Virus Vaccine Inactivated; Celecoxib

View more View all content updates